ReviewBiologics : targets & therapy2019
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.
Michelle E Keyel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled ittrialcites it